Literature DB >> 1505912

Biochemical and histopathological correlation in liver transplant: the first 180 days.

K S Henley1, M R Lucey, H D Appelman, P Baliga, K A Brown, G D Burtch, D A Campbell, J M Ham, R M Merion, J G Turcotte.   

Abstract

It is not known whether the histopathology of the liver allograft can be predicted from biochemical measurements in serum with the same confidence as in the native liver. To answer this question we compared the histopathological diagnoses in 170 biopsy specimens from 70 adult transplant recipients obtained during the first 180 days, with the concentrations of the serum bilirubin and the activities of AST, ALT and alkaline phosphatase measured at the same time. The most frequent diagnosis was cholestasis (n = 45), which was mild, moderate or severe and which may have been complicated by rejection (n = 28) or ischemia (n = 14). Hepatitis (n = 14), ischemia with rejection (n = 6) and spotty focal necrosis (n = 6) were diagnosed less frequently. Fifteen biopsy specimens were reported as histopathologically normal. In general, biochemical measurements discriminated poorly between different histopathological diagnoses. The histopathologically normal liver often showed an abnormal pattern of enzymes and an increase in the serum bilirubin level. As a result histopathologically normal biopsy specimens were indistinguishable biochemically from those with hepatitis. When two pathological conditions were found to coexist (e.g., cholestasis with either rejection or ischemic necrosis, or ischemic necrosis with rejection), the effect on the serum biochemistry was usually not additive and in some instances returned the biochemical abnormalities toward normal. With the exception of the serum bilirubin level, which increased with the severity of uncomplicated cholestasis, we could not identify a specific pattern of biochemical changes corresponding to a given histopathological diagnosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505912     DOI: 10.1002/hep.1840160312

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report.

Authors:  T Hranjec; H Bonatti; A L Roman; C Sifri; S M Borowitz; B H Barnes; T R Flohr; T L Pruett; R G Sawyer; T M Schmitt
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 2.  Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rinkesh K Bansal; Neeraj Saraf; Dheeraj Gautam; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-11-07

3.  Neutrophil-to-lymphocyte ratio predicts early acute cellular rejection in living donor liver transplantation.

Authors:  Boram Lee; YoungRok Choi; Jai Young Cho; Yoo-Seok Yoon; Ho-Seong Han
Journal:  Ann Surg Treat Res       Date:  2020-11-26       Impact factor: 1.859

4.  Association between IRF1 Gene Expression and Liver Enzymes in HBV-infected Liver Transplant Recipients with and without Experience of Rejection.

Authors:  S H Nabavizadeh; S Janfeshan; M H Karimi; A Eidi; R Yaghobi; A Afshari; B Geramizadeh; S A Malek-Hosseini; F Kafilzadeh
Journal:  Int J Organ Transplant Med       Date:  2018-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.